Supported by the Australian Government’s Medical Research Future Fund (MRFF), the Stroke Foundation is facilitating a targeted clinical research investment in recovery for working age survivors of chronic stroke through two dedicated research grants funded from 2019-2021:
- Clinical Trial: Perispinal Etanercept (PSE) as a therapy promoting recovery after chronic stroke for younger stroke survivors in Australia (particularly those of working age). This is a 2.5 year grant of up to AUD $750,000.
- Clinical Trial: Return to work (RTW) for younger stroke survivors in Australia. This is a 2.5 year grant of up to AUD $250,000.
The ‘Return to life, return to work’ initiative will fund projects aimed at developing innovative recovery and rehabilitation clinical interventions for younger stroke survivors in Australia – an emerging priority area with unmet needs. These projects will continue to accelerate important neurological research and support Australian researchers to be at the forefront of finding solutions for stroke recovery.
- View Application Guidelines (PDF) for eligibility details
Submission Requirements & Due Date
- Applications must be submitted for internal review by 23 November 2018
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review